America is in danger of health.

a study released by the "Tech Branch" of the U.SFood
Drug
administration(FDA), a panel of advisory panels, said the FDA can no longer provide adequate protection for thesupply of u.Sfood anddrugs, a situation that is largely due to the lack of funding and lack of tight organization of the FDAOver the past 20 years, the FDA's responsibilities have increased, yet budgetary funding has barely budgedAt present, the FDA's access to funds is far from keeping pace with the regulatory situation of the FDA's high demands, this imbalance is food,drugs, cosmetics andmedical devicesregulatory systems pose a serious threat to public safetyTo make matters worse, the FDA itself is flawed and cannot afford regulatory responsibilitiesMark Fendrick, a professor of management and policy at the University of Michigan's Department of Internal Medicine andHealth, says the FDA needs to change its definition of drug safety and efficacy in addition to fundingBecause money alone doesn't solve the paradox that Americans want to use new products in a timely manner, but they can't tolerate any flawsThe report also notes that the FDA's "50-year-old approach" and its failure to keep up with scientific developments in time mean stake swells American livesThe report also calls for training FDA researchers to improve the agency's computer systems, which are outdated and prone to malfunctionAt present, the FDA is not yet able to quickly compare and analyze the risk reports of relevant products, inspectors work reports still need to be handwritten, greatly affecting the speed of implementation of the relevant workIn addition, systems that manage imported products are unable to communicate with customers and other government systemsHowever, Sidney Wolfe, director of the healthresearch groupat consumer group Public Citizen, said the new report's "biased and simplistic" look at the FDA's problems seemed to emphasize more of the importance of industry satisfaction with the FDA and no expressionHe noted that the FDA needs to overhaul the industry, including new legislation to further strengthen regulation of food additives, pharmaceuticals and dietary supplements, and abandon the practice of user fees paid by pharmaceutical companies andmedical devicesmanufacturersVarious food and drug recalls in recent years have undermined public trust in the FDAA recent survey found that 47 percent of Americans think the FDA's job performance is generally or poorA study published in September in the Journal of Internal Medicine found that between 1998 and 2005, the number of adverseof serious drugreactions in the United States more than doubled, from 34,966 to 89,842, and the number of deaths from adverse drug more than doubled to 15,107 During that period, the number of outpatient prescriptions in the United States increased from 2.7 billion to 3.8 billion In other words, adverse drug events are growing four times faster than outpatient prescriptions